LUNIT INC
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research--Findings to be Presented at SITC 2022 2022-11-07 21:00
Real-World Application of Lunit INSIGHT to be Spotlighted at RSNA 2022 (Oral Presentations) 2022-11-01 22:00
Lunit Joins World Economic Forum Global Innovators Community 2022-10-26 21:00
Lunit Showcases AI Solutions for Radiology at AOCR & KCR 2022 2022-09-21 22:48
New Study by Lunit and MGH Validates Effectiveness of AI as Aid in Chest X-Ray Interpretation - Published in JAMA Network Open 2022-09-13 22:16
Lunit Introduces AI for TB Screening to Indonesia Ministry of Health Officials 2022-09-07 21:00
Lunit to Showcase 5 Abstracts at ESMO 2022 2022-09-05 21:00
Lunit AI Solution for Breast Cancer Detection Wins Commercial Approval in Taiwan 2022-08-25 23:13
Lunit Announces Financial Results for the First Half of 2022 2022-08-12 21:00
New Immunotherapy Combination Study for Nasopharyngeal Cancer Demonstrates Effectiveness of Lunit AI as Predictive Aid in Treatment Outcome--Published in Clinical Cancer Research 2022-08-01 21:00
AI-based Cancer Solution Pioneer Lunit Makes Market Debut 2022-07-21 21:00
Lunit to be Listed on KOSDAQ next week 2022-07-14 21:00
Cathay Life Insurance to Incorporate Lunit AI Solution for Chest X-Ray into Underwriting Workflow 2022-07-06 21:00
Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System 2022-07-04 21:00
Lunit Files Registration Statement for Initial Public Offering 2022-06-16 21:00
New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment 2022-05-27 08:30
Lunit AI Biomarker PD-L1 Demonstrates Clinical Efficacy as Diagnostic Aid in Cancer Treatment-Published in the European Journal of Cancer 2022-05-19 21:00
Lunit to Present 11 Abstracts at the 2022 ASCO Annual Meeting 2022-04-28 21:33
Medical AI Startup Lunit gets Preliminary Approval to go Public on KOSDAQ 2022-04-21 22:12
New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities 2022-04-06 21:44
1 4 5 6 7 8